Amesite is trading at $0.59, up +7.83%, with no clear company-specific catalyst identified for the after-hours rise. - Amesite’s investor-relations page lists its latest release as September 24, about a new NurseMagic sales win. - Reuters reported software stocks weakened amid disappointing Fortinet and ServiceNow results, but that sector context does not explain Amesite’s move higher. - No after-hours volume or activity data was provided.